Women with kidney disease are undertested, undertreated and left behind by decades of male-dominated research

Women with chronic kidney disease are less likely than men to be diagnosed, represented in research and given treatments that have been properly tested in them.

That is the central finding of a new paper published today in The Lancet, which warns that decades of male-dominated clinical research have left women systematically disadvantaged at every stage of the disease.

Chronic kidney disease already affects 844 million adults worldwide and is projected to become the fifth leading cause of death globally by 2040. ...